86: Larry Fink On The Power of Capitalism

BlackRock
00:26:17 Report Issue
Loading transcript... Click for full transcript

Chapters & Sections (38)

00:02 Introduction and Context of BlackRock Letters chapter 2
00:02 Host Introduction and Guest Overview
00:35 Larry Fink’s Letter Tradition and Motivation
01:05 Purpose and Long‑Term Focus of the Letters chapter 2
01:05 Short‑Term Market Narratives vs. Long‑Term Value Creation
02:39 Fiduciary Responsibility and Client Focus
03:11 Capitalism, Stakeholder Capitalism, and Climate Change chapter 3
03:11 The Power of Capitalism Theme
04:16 Stakeholder Capitalism Explained
05:19 Capitalism’s Role in Society and Climate Risk
06:52 Talent Management in the Pandemic Era chapter 2
06:52 Employer‑Employee Relationship During the Pandemic
07:53 Talent Retention and Competitive Advantage
08:55 Employee Engagement and Purpose chapter 2
08:55 Turnover Rates and Employee Connectivity
09:28 Purpose-Driven Culture and Retention
09:59 Capital Access, Disruption, and Market Dynamics chapter 3
09:59 Capital Market Expansion and Competitive Pressure
10:32 Disruption Awareness for Incumbents
11:03 Opportunities in Decarbonization and Renewal
12:04 Sustainability, Decarbonization, and Investor Priorities chapter 4
12:04 Investor Preference for Sustainable Strategies
12:35 Capital Flow into Sustainability Initiatives
13:07 Challenges of Fair and Just Decarbonization
14:12 Government and Business Collaboration for Transition
15:15 Investment Opportunities and Technological Innovation chapter 3
15:15 Decarbonization Pathways and Technological Development
16:17 Role of Traditional Energy Companies in Net Zero
17:20 Investment Strategy for Startups and Incumbents
17:52 Larry Fink on Green Innovation and Market Resilience chapter 7
17:52 Opportunities in Green Hydrogen and Cement
18:24 Lessons from a Decade of Market Crises
18:57 Optimism as a Long‑Term Strategy
19:29 Resilience in Capitalism and Stakeholder Value
19:59 Building an Inclusive Future
20:30 Capital Markets Driving Wealth Creation
21:01 mRNA Technology and Future Medical Solutions
21:32 Legal Disclaimer and Regulatory Information chapter

Transcript

Loading transcript...